09/12/2022at 15:04

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

Novo Nordisk hopes to retain employees with share gift

All Novo Nordisk employees have been offered 37 restricted stock units, which can be turned into real B shares in Aug. 2026.

For subscribers

Luja can potentially solve a long-lived UTI problem for people who need help with bladder control issues by using new micro-hole technology

Medtech

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

For subscribers

Medtech

Coloplast launches male catheter featuring new technology

For subscribers

Medtech

Coloplast's bottom line disappoints in otherwise strong report

For subscribers

Nu mangler kun en endelig vedtagelse i EU-Parlamentet, før lovforslag om at udskyde deadlines for nye krav til medicinsk udstyr. er en realitet. | Foto: Thomas Borberg/Ritzau Scanpix

Medtech

Another hurdle overcome in delaying MDR deadline

For subscribers

Other

EU Commission to give more time for MDR transition

A proposal meant to mitigate potential medical device shortages under the Medical Device Regulation is now headed to the European Parliament and Council under an accelerated procedure.

For subscribers

Pharma & biotech

FDA approves Novo Nordisk's Rybelsus as first-line treatment option

Rybelsus, the tablet formulation of semaglutide, has now been approved in the US as a first-line treatment option for adults with type 2 diabetes.

For subscribers

Pharma & biotech

Novo Nordisk declared world's best place to work in 2022

The Best Places to Work organization has released its 2022 list of the best workplaces across the world, and Danish Novo Nordisk shines at the top.

For subscribers

Latest news

See all

Jobs

See all jobs

Jobs

See all jobs

Microsoft is in the process of discontinuing Internet Explorer – and so are we.
For a better experience, we recommend using one of the following browsers.

Kind regards,
MedWatch

Top news from MedWatch this week

Monday

Tuesday

Wednesday

Thursday

Friday

Sign up for our newsletter

Front page now

Novo Nordisk hopes to retain employees with share gift

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

Coloplast launches male catheter featuring new technology

Coloplast's bottom line disappoints in otherwise strong report

Another hurdle overcome in delaying MDR deadline

Top news from MedWatch this week

Further reading

EU Commission to give more time for MDR transition

FDA approves Novo Nordisk's Rybelsus as first-line treatment option

Novo Nordisk declared world's best place to work in 2022

Latest news

Jobs

Jobs